Publications

clinical significance of respiratory syncytial virus.		1964	14163254
reye syndrome with associated influenza a and b infection.	in early 1974, seventeen children were treated for reye syndrome. thirteen of these were studied for laboratory evidence of concomitant viral infection. influenza b/hong kong was isolated from the pharynx in four of nine 1974 cases tested. one child had just recovered from varicella. adenovirus type 2 and respiratory syncytial virus were isolated from two additional patients. serologic tests for influenza suggested concomitant or recent influenza b infection in ten of 13 of 1971 cases. during fe ...	1975	1174373
respiratory syncytial virus infections in pediatric liver transplant recipients.	respiratory syncytial virus (rsv) is the most important cause of lower respiratory tract infection in infants and young children. the charts of 17 children found to have rsv among 493 children who underwent liver transplantation between february 1985 and february 1991 were reviewed. the median age at diagnosis was 20 months. median time of diagnosis was 24 days after transplantation. thirteen patients developed nosocomial infections while convalescing from their transplant. common symptoms inclu ...	1992	1727886
rate of concurrent otitis media in upper respiratory tract infections with specific viruses.	to estimate the coincidence of new otitis media (om) for first nasopharyngeal detections of the more common viruses by polymerase chain reaction (pcr). new om episodes are usually coincident with a viral upper respiratory tract infection (vurti), but there are conflicting data regarding the association between specific viruses and om.	2009	19153302
medical utilization associated with palivizumab compliance in a commercial and managed medicaid health plan.	respiratory syncytial virus (rsv) is the leading cause of lower respiratory tract infections and hospitalization in infants. palivizumab is currently the only available agent for prevention of rsv infection in high-risk infants. this high-cost injectable requires monthly dosing during the rsv season. compliance with the injection schedule is important in the prevention of rsv infection and respiratory complications. managed care organizations have an interest in the relationship between complian ...	2010	20044844
a prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.	community-acquired respiratory viral infections (rvis) are common in lung transplant patients and may be associated with acute rejection and bronchiolitis obliterans syndrome (bos). the use of sensitive molecular methods that can simultaneously detect a large panel of respiratory viruses may help better define their effects.	2010	20075787
the use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics?	because extensive antibiotic use by inpatients has been associated with the development of multidrug-resistant organisms, we aimed to determine which variables were associated with the use of antibiotics after viral respiratory tract infection diagnosis among adult patients admitted to the hospital with respiratory symptoms.	2010	20923284
vaccination strategies against respiratory syncytial virus.	respiratory syncytial virus (rsv) is the most common cause of us infant hospitalization. additionally, rsv is responsible for 10,000 deaths annually among the elderly across the united states, and accounts for nearly as many hospitalizations as influenza. currently, several rsv vaccine candidates are under development to target different age groups. to evaluate the potential effectiveness of age-specific vaccination strategies in averting rsv incidence, we developed a transmission model that int ...	2016	27799521